Maxwell D. Cummings
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Computational Drug Discovery Methods, Monoclonal and Polyclonal Antibodies Research, Hepatitis B Virus Studies
Most-Cited Works
- → Structure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb3,(1998)427 cited
- → Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells(2005)425 cited
- → Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance(2010)299 cited
- → Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation(2014)243 cited
- → Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor(2014)211 cited
- → In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435(2010)210 cited
- → Comparison of Automated Docking Programs as Virtual Screening Tools(2005)206 cited
- → Docking: Successes and Challenges(2005)204 cited
- → Universal Screening Methods and Applications of ThermoFluor®(2006)173 cited
- → 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR(2004)166 cited